Prognostic Value of Porta-Hepatis Lymphadenopathy in Children with Hepatitis A

Amin Mashhadi1, Manijeh Khalili2, Alireza Ansari Moghaddam3

  • 1Department of Radiology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.

Insights

Porta-hepatis lymphadenopathy (PHL) and para-aortic lymphadenopathy do not significantly impact hepatitis A prognosis in children. However, ultrasound findings may indicate disease severity in pediatric hepatitis A patients.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Diagnostic Imaging

Background:

  • Hepatitis A virus (HAV) infection is a common cause of acute liver inflammation in children.
  • Porta-hepatis lymphadenopathy (PHL) is a potential ultrasound finding in HAV infection.
  • The prognostic significance of PHL in pediatric HAV is not well-established.

Purpose of the Study:

  • To investigate the prognostic value of porta-hepatis lymphadenopathy (PHL) in children diagnosed with hepatitis A virus (HAV).
  • To assess the correlation between lymphadenopathy (porta-hepatis and para-aortic) and clinical outcomes in pediatric HAV patients.

Main Methods:

  • A prospective cohort study included 123 pediatric patients with confirmed hepatitis A.
  • Patients were grouped based on porta-hepatis lymph node size (>6 mm vs. <6 mm) and para-aortic lymphadenopathy presence.
  • Laboratory results and hospital stay duration were compared between groups.

Main Results:

  • Patients with larger porta-hepatis lymph nodes showed significantly higher liver enzyme levels (AST, ALT, ALP).
  • Para-aortic lymphadenopathy was associated with elevated laboratory test results, excluding bilirubin.
  • No significant correlation was found between the presence of porta-hepatis or para-aortic lymphadenopathy and patient prognosis.

Conclusions:

  • Porta-hepatis lymphadenopathy and para-aortic lymphadenopathy do not appear to be significant prognostic indicators in pediatric hepatitis A.
  • Abdominal ultrasound findings, including lymphadenopathy, may assist in evaluating disease severity in children with hepatitis A.
Abstract